A detailed history of Mackenzie Financial Corp transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 8,913 shares of BBIO stock, worth $247,514. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,913
Holding current value
$247,514
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.91 - $31.3 $213,109 - $278,976
8,913 New
8,913 $226,000
Q4 2023

Jan 30, 2024

BUY
$24.02 - $43.89 $167,947 - $306,878
6,992 New
6,992 $282,000
Q4 2021

Feb 14, 2022

SELL
$11.38 - $53.41 $71,432 - $335,254
-6,277 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$46.87 - $64.24 $123,033 - $168,630
2,625 Added 71.88%
6,277 $294,000
Q2 2021

Aug 11, 2021

BUY
$46.47 - $63.93 $169,708 - $233,472
3,652 New
3,652 $223,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.12B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.